SUSAN OLIVER: Open Payments
NPI 1548874159 · BELLEVILLE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$451 in 37 payments from 7 companies in 2025. Trend: 2023 $709 · 2024 $743 · 2025 $451
Food & beverage: $443Education: $8
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 28 | $221 |
| E.R. Squibb & Sons, L.L.C. | 1 | $88 |
| ABBVIE INC. | 2 | $36 |
| Corium, LLC | 2 | $36 |
| Tris Pharma Inc | 2 | $29 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
Products named: Qelbree, COBENFY, VRAYLAR, Azstarys, Dyanavel XR, Jornay PM, TRINTELLIX.
Industry payments across KS — which companies pay providers there.
